The FDA has completed its 30-day review of an application for Hepzato…
Month: April 2025
225 posts
Patient and Disease-Related Factors Influence Outcomes in Urothelial Cancer
Patient and disease-related factors influence surgical recovery and treatment outcomes after Keytruda…
Aidixi Plus Bacillus Calmette-Guérin Effective in Bladder Cancer
Aidixi plus BCG showed strong early efficacy and manageable safety in patients…
CM24 Combo With Biomarker Targeting Improves Survival in Pancreatic Cancer
CM24 plus Opdivo and chemo improved survival in pancreatic cancer with CEACAM1…
Lingering Stress After Follicular Lymphoma Remission is a Challenge
Four years after remission from follicular lymphoma, ongoing fear of relapse, lingering…
Larger Tumor Size Linked to Higher Mortality Risk in Brain Cancer
Investigators shared real-world data showing a clear and consistent association between increased…
Pembrolizumab’s Perioperative Power in Head and Neck Cancer
For more than two decades, patients diagnosed with locally advanced head and…
SENTI-202 Shows Positive Preliminary Data in Acute Myeloid Leukemia
A phase 1 trial evaluating SENTI-202 demonstrated positive preliminary results in treating…
Daily Takeaways From the AACR Annual Meeting 2025: Monday, April 28
The fourth day of the AACR Annual Meeting 2025, a sunny and…
An AI-Driven Companion Diagnostic Receives FDA Designation in NSCLC
The Ventana TROP2 RxDx Device, a computational companion diagnostic, was granted breakthrough…
Investigating the Addition of Surgery to ICI Therapy in Kidney Cancer
Dr. Hyung L. Kim discusses how the addition of cytoreductive nephrectomy to…
TAR-200 Shows High Response Rates in Bladder Cancer Subset
TAR-200 showed high complete response rates in BCG-unresponsive, high-risk non-muscle invasive bladder…
